Evexia Wealth’s Zomedica Corp. ZOM Stock Holding History

Evexia Wealth’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-35,000	Closed	-$4.72K	–	65
2024 Q1	$4.72K	Hold	35,000	–	–	﹤0.01%	58
2023 Q4	$4.61K	Buy	+35,000	New	+$6.15K	﹤0.01%	56

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Evexia Wealth's ZOM Position: Q2 2024 in Review

Evexia Wealth sold out of Zomedica Corp. (ZOM) in Q2 2024, closing a stake of 35,000 shares — an estimated $4.72K sold.

Evexia Wealth first reported a position in ZOM in Q4 2023 and held it in 2 quarters. The position peaked at $4.72K in Q1 2024. 96 funds tracked by Wall St. Rank hold ZOM as of Q2 2024.

Evexia Wealth reported no remaining Zomedica Corp. position as of Q2 2024 after selling out during the quarter.
Evexia Wealth sold 35,000 Zomedica Corp. shares in Q2 2024, an estimated $4.72K.
Evexia Wealth first reported a position in Zomedica Corp. in Q4 2023 and held it in 2 quarters.
Evexia Wealth's Zomedica Corp. position peaked at $4.72K in Q1 2024.
96 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2024.

Based on Evexia Wealth's 13F filing for Q2 2024, filed 31 Jul 2024.